Sulfadoxine-pyrimethamine is one of the alternative antimalarial drugs used to treat chloroquine-resistant Plasmodizm fakiparum malaria. The molecular target of sulfadoxine, an analog of p-aminobenzoic acid that inhibits the folate biosynthetic pathway, is dihydropteroate synthase (DHPS). The nucleotide sequence of the DHPS gene was determined in 32 clinical isolates obtained in Yaounde, Cameroon, and compared with the sequence of reference clones and Cambodian strains of P. falciparuin. Of the 32 Cameroonian isolates, 31 displayed one of the sulfadoxinesensitive mutation patterns: Ala-436/Ala-437/Ala-58 1/Ala-613 (n = 20), Ser-436/Gly-437/Ala-58 l/Ala-613 (n = 6),
Ser-436/Ala-437/Ala-581/Ala-613 (n = 4), and Ala-436/Gly-437/Ala-581/Ala-613 (n = 1). One isolate had a sulfadoxine-resistant profile characterized by a double mutation: Phe-436/Ala-437/Ala-58 Mer-613. Although the majority of the isolates had a sulfadoxine-sensitive genetic profile, further studies are needed to correlate the mutation patterns and in vitro and in vivo sulfadoxine sensit%ty.
An increasing number of malaria-infected patients are currently being treated with sulfadoxine-pyrimethamine in Cameroon because of the high rate of treatment failure with chloroquine.' Increasing drug pressure may favor the selection of antifolate-resistant Plasnlodiuin falcipamm mutants? In fact, our recent studies provide evidence that pyrimethamine-resistant P. fakiparum isolates are present in Yaounde.3~~ Pyrimethamine acts synergistically with sulfadoxine, a competitive inhibitor of dihydropteroate synthase (DHPS). This enzyme catalyzes the formation of dihydropteroate from p-aminobenzoic acid (PABA) and 6-hydroxymethyldihydropterine pyrophosphate in the folate biosynthetic pathway? Dihydropteroate is converted to dihydrofolate, which in turn is transformed into tetrahydrofolate by DHFR, the target enzyme of pyrimethamine. Sulfadoxine is a structural analog of p-aminobenzoic acid and, together with pyrimethamine, inhibits the folate biosynthetic pathway in a sequential manner. This results in a marked synergism between the two antifolate drugs. 6 The molecular mechanism by which P. falciparum develops resistance to sulfadoxine has not been elucidated. Recent studies on the P. fakiparum DHPS gene have suggested that as in the case of the dihydrofolate reductase-thymidylate synthase (DHFR-TS) gene, point mutations at discrete positions may be associated with sulfadoxine resistance.7. s So far, published data on the DHPS gene have been based on culture-adapted, reference clones of P. falciparui~~7-~ The present study was conducted to extend the observations from previous studies and to define the genetic profile of the DHPS gene in fresh clinical isolates of P. falciparurn obtained from symptomatic Cameroonian patients in Yaounde.
MATERIALS AND METHODS
Parasite DNA. Thirty-two clinical isolates of P. falciparum were obtained before treatment from symptomatic Cameroonian patients consulting the Nlongkak Catholic missionary dispensary in Yaounde in 1994-1995. The study was approved by the Cameroonian National Ethics Committee and the Ministry of Health. Informed-consent was obtained before blood exträctiön. %Í&-broÓd s y p l e s (5-10 ml of whole blood) The polymerase chain reaction was performed using the PTC-100 thermocycler (MJ Research, Watertown, MA) under the following conditions €or a total of 30 cycles: denaturation at 94°C for 5 min for the first cycle and 1 minute in subsequent cycles, annealing at 50°C for 5 min for the first cycle and 1 min in subsequent cycles, and extension at 72°C for 10 min for the first cycle and 1 min in subsequent cycles. One-tenth of the amplified product was loaded on a 1% agarose gel, electrophoresed, and stained with ethidium bromide, to visualize the expected 708-basepair band by ultraviolet transillumination.
Cloning. The amplified product was purified by chloroform:isoamyl alcohol (24: 1 [v/v]) extraction and approximately 50-100 ng of the polymerase chain reaction product was ligated into 50 ng of pMOSBlue T-vector (Amersham International, PLC, Buckinghamshire, United Kingdom) fol-
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- lowing the manufacturer's instructions. The recombinant vector was transformed into DH5a competent cells and screened for positive colonies by the a-complementation test (blue/white test). The positive colonies were further screened for the expected size of the insert by polymerase chain reaction, using T7 and U19 universal primers. The colonies were grown in Luria-Bertani liquid medium overnight, and the recombinant plasmid was extracted using the standard alkaline lysis method for minipreparation of plasmid DNA.Io DNA sequencing. The double-stranded recombinant plasmid was denatured by the addition of 0.2 N NaOH and incubated for 5 min in a 37°C water bath. One of the oligonucleotide primers PfDHPS1 or F'fDHPS2 (2 pmol) was added to allow to anneal for 5 min at 37°C. The plasmid was precipitated with 0.3 M potassium acetate and absolute ethanol and washed with 70% ethanol. After drying the pellet, the plasmid was suspended in a standard mixture for the sequencing reaction. To initiate the dideoxy chain termination reaction,II T7 DNA polymerase (Pharmacia, Uppsala, Sweden) was added.
The DNA sequence was determined to identify the codons at positions 436, 437, 581, and 613. According to Brooks and others7 and Triglia and Cowman: in vitro sulfadoxine sensitivity is defined by Ser-or Ala-436/Gly-or Ala-437/Ala-581/Ala-613. Two distinct genetic profiles were associated with sulfadoxine-resistance in these studies: a K1type single point mutation at position 581 (Ser-436/Gly-437/Gly-581/Ala-613) and a W2-type double mutation at positions 436 and 613 (Phe-4361Gly-or Ala-437/Ala-58 Weror Thr-613). Since the in vitro sulfadoxine sensitivity of the Cameroonian isolates was not determined, the genetic profiles of the parasites used in this study were interpreted on the basis of the above-mentioned criteria.
RESULTS
Most of the nucleotide variations were found in codons 436 and 437. Except for three Cambodian strains with the mutant Gly-581, all Parasites had a wild-type codon Ala- for the DHPS domain of the gene. Using reference clones of P. falciparum, these two studies have identified four COdon sites within the coding region of the DHPS domain that may undergo mutation. To identify the codon sequences, Wang and othersg have described a polymerase chain reaction protocol using allele-specific oligonucleotides. Although "a similar polymerase chain reaction strategy has been used successfully to detect point mutations in the P. falciparum DHFR-TS gene,1r15 in our experience, this technique requires a highly reliable thermal cycler and needs fine adjustment of oligonucleotide primer length, annealing temperature, and MgCl, concentration to optimize amplification conditions that allow discrimination of a single-base mismatch in the target alleles. We preferred using a more reliable DNA sequencing to establish the baseline genetic profile of clinical isolates in Cameroon.
In this study, the DNA sequences of four variable codons of the DHPS gene were determined in 32 Cameroonian isolates and compared with those of the reference clones of P. falciparuni. The sequences of 3D7, W2, 7G8, and FCR3 determined in our study corresponded exactly with those that were published previously?,a The DHPS genetic profile of HB3IHonduras was not published in the previous studies. Our sequence of the D6 clone (Ala-436lAla-4371Ala-581/Ala-613) does not agree with the published sequence (Phe-436/Ala-437/Ala-581/Ser-613). The underlying reason may involve cross-contamination of the stock parasites andor independent mutations arising in different subclones grown in various laboratories.
Based on the criteria proposed by Brooks and others7 and Triglia and Cowman: 31 of 32 Cameroonian isolates obtained from symptomatic indigenous patients residing in Yaounde were sensitive to sulfadoxine. Only one Cameroonian isolate displayed a sulfadoxine-resistant genetic profile similar to that of W2lIndochina clone. This isolate exhibited the pyrimethamine-sensitive phenotype Ser-108 in the DHFR-TS gene and was sensitive in vitro to both pyrimethamine (50% inhibitory concentration [IC,,] = 12 nM) and cycloguanil (IC5, = 6.5 nM). Among the resistant parasites, the KWThailand-type pattern was observed in three Cambodian strains. This profile has so far been noted exclusively in parasites originating from Southeast Asia. The W2type was seen in only one African isolate.
Unlike the case of the enzyme DKFR, the crystal structure of DHPS of any organism has not been determined. It is therefore not known at present whether the four variable codons of the malarial DHPS gene modify or not the conformation of the active site. Sulfadoxine resistance is probably not associated with gene amplification?, a Other possible mechanisms of sulfadoxine resistance that need to be explored include diminution of drug uptake and increased de novo synthesis of p-aminobenzoic acid. I6-l8 In this study, the sulfadoxine sensitivity of the Cameroonian isolates was not determined in vitro or in vivo since the objective of our analysis was to establish the baseline sequence data. The absence of the sensitivity data does not allow US to draw a definite conclusion regarding the correlation between the genetic profile and drug sensitivity in the Cameroonian isolates. Since sulfadoxine-pyrimethamine is one of the most promising candidates to replace chloroquine in Africa, the importance of further studies on the genetic pattern of the DHPS gene cannot be underestimated.
Addendum. In a recent publication,lg the criteria of in vitro sulfadoxine resistance were modified. Sulfadoxine sensitivity is defined by Ser-436 (or Ala-436), Ala-437, Ala-581, and Ala-613 (FCR3 type pattern). Moderate sulfadoxine resistance is now defined by a 3D7 type pattern with a single Ala-to-Gly mutation in codon 437. Higher levels of sulfadoxine resistance are associated with double (Ser-436, Gly-437, Gly-581, Ala-613; K1 type) or triple (Phe-436, Gly-437, Ala-581, Ser-613; W2 type) DHPS mutations. According to the revised classification, seven Cameroonian isolates presented in Table 2 (Ser-or Ala-436, Gly-437, Ala-581, Ala-6 13) are moderately sulfadoxine resistant, while one Cameroonian isolate (Phe-436, Ala-437, Ala-581, Ser-613; W2 type) is highly sulfadoxine resistant.
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